¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13
±³À°ÀÏÀÚ : 2024-07-13
±³À°Àå¼Ò : ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ

±³À°ÁÖÁ¦ : 2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ

ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Àç°ü·ùÄ¡·á¿¬±¸È¸

´ã´çÀÚ : Àç°ü·ùÄ¡·á¿¬±¸È¸
¿¬¶ôó : 02-2228-1614

À̸ÞÀÏ : reperfusion119@gmail.com

±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 20,000¿ø  

ºñ°í ȸ¿ø 1¸¸¿ø, ºñȸ¿ø 2¸¸¿ø(Àü°øÀÇ ¹«·á)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 09:00~09:20 Recent researches in endovascular treatment ±ÇµÎÇõ(¿µ³²´ëº´¿ø ½Å°æ°ú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 09:20~09:40 Machine learning and artificial intelligence-based approach in reperfusion treatment ÇãÁسç(Á߾Ӵ뱤¸íº´¿ø ½Å°æ°ú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 09:40~10:00 New devices and techniques in endovascular treatment °ûÈ¿¼º(ÀüºÏ´ëº´¿ø ¿µ»óÀÇÇаú)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 10:00~10:10 QnA ( )

ÈÞ½Ä 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 10:10~10:20 Coffee Break ( )

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 10:20~10:40 Utility of thrombus characteristics in intravenous thrombolysis ¹ÚÇüÁ¾(°è¸í´ëµ¿»êº´¿ø ½Å°æ°ú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 10:40~11:00 Radiological and histological characteristics of thrombus in endovascular treatment ¹éÀåÇö(°­ºÏ»ï¼ºº´¿ø ½Å°æ°ú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 11:00~11:20 Applicability of hemostasis or coagulation assay in stroke management ¼ÛÅÂÁø(ÀÌ´ë¼­¿ïº´¿ø ½Å°æ°ú)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 11:20~11:30 QnA ( )

±âŸ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 11:30~11:45 ÃÑȸ ( )

½Ä»ç 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 11:45~13:00 Lunch ( )

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 13:00~13:20 Tenecteplase vs. alteplase: Evaluating superiority ¿ìÈ£°É(°æÈñ´ëº´¿ø ½Å°æ°ú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 13:20~13:40 Usefulness of tenecteplase in various conditions: Extended time window and endovascular treatment ¹é¹Î·Ä(¿ëÀμ¼ºê¶õ½ºº´¿ø ½Å°æ°ú)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 13:40~13:50 QnA ( )

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 13:50~14:05 Current global recommendations for door-to-puncture time ±èº¸±Ô(°í´ë¾È¾Ïº´¿ø ¿µ»óÀÇÇаú)

±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 14:05~14:20 Current status of door-to-puncture time in Korea: Realities and challenges ÀÌÁ¤À±(¼øõÇâ¼­¿ïº´¿ø ½Å°æ°ú)

Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±â³ä°ü ÄÁº¥¼ÇȦ 14:20~14:40 Panel discussion ±èÁØÈÖ Á¤¿ì»ó ¼­Á¤È­ ¹ÚÁ¤Áø(¿ëÀμ¼ºê¶õ½ºº´¿ø ¾ÆÁִ뺴¿ø ºÎ»ê¹éº´¿ø °Ç±¹´ëº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û õ½Ä¿¬±¸È¸ Workshop 2024 : 2024-07-13
´ÙÀ½±Û Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(1ÀÏÂ÷) : 2024-07-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20898 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 49 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 39 2024-05-28
20896 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 62 2024-05-28
20895 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 45 2024-05-28
20894 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 13 2024-05-28
20893 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 31 2024-05-28
20892 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 35 2024-05-28
20891 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 53 2024-05-28
20890 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 150 2024-05-27
20889 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 85 2024-05-27
20888 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 192 2024-05-27
20887 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 78 2024-05-27
20886 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 36 2024-05-27
20885 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 56 2024-05-27
20884 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 72 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷